Literature DB >> 2245177

Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.

P Lissoni1, G Tancini, F Rovelli, G Cattaneo, C Archili, S Barni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2245177      PMCID： PMC1971518          DOI： 10.1038/bjc.1990.389

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  8 in total

1.  Endorphins, immune function, and cancer.

Authors:  J E Morley; N Kay; J Allen; T Moon; C J Billington
Journal:  Psychopharmacol Bull       Date:  1985

2.  A study on the relationship between the pineal gland and the opioid system in patients with cancer. Preliminary considerations.

Authors:  D Esposti; P Lissoni; G Tancini; S Barni; S Crispino; F Paolorossi; F Rovelli; L Ferri; G Cattaneo; G Esposti
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

3.  Brain serotonin concentration: elevation following intraperitoneal administration of melatonin.

Authors:  F Anton-Tay; C Chou; S Anton; R J Wurtman
Journal:  Science       Date:  1968-10-11       Impact factor: 47.728

4.  Neurohumoral mechanisms of the formation of antitumoral activity.

Authors:  V B Vinnitsky
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  Letter: The pineal and neoplasia.

Authors:  R S Buswell
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

6.  A survey of the location, isolation and identification of indoles, pteridines and some unknown active substances in sheep pineals. The possible significance of pteridines for the neuroendocrine control of neoplastic growth.

Authors:  I Ebels
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

7.  Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer.

Authors:  E Nakayama; S Asano; N Takuwa; J Yokota; S Miwa
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

8.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307
  8 in total
  3 in total

1.  Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

Authors:  Dalil Hannani; Marie Vétizou; David Enot; Sylvie Rusakiewicz; Nathalie Chaput; David Klatzmann; Melanie Desbois; Nicolas Jacquelot; Nadège Vimond; Salem Chouaib; Christine Mateus; James P Allison; Antoni Ribas; Jedd D Wolchok; Jianda Yuan; Philip Wong; Michael Postow; Andrzej Mackiewicz; Jacek Mackiewicz; Dirk Schadendorff; Dirk Jaeger; Inka Zörnig; Jessica Hassel; Alan J Korman; Keith Bahjat; Michele Maio; Luana Calabro; Michele Wl Teng; Mark J Smyth; Alexander Eggermont; Caroline Robert; Guido Kroemer; Laurence Zitvogel
Journal:  Cell Res       Date:  2015-01-13       Impact factor: 25.617

Review 2.  Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function.

Authors:  J Fukata; H Imura; K Nakao
Journal:  J Endocrinol Invest       Date:  1994-02       Impact factor: 4.256

3.  Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.

Authors:  M E Gore; P Riches; K MacLennan; M O'Brien; J Moore; G Dadian; A Lorentzos; R Garth; E Moskovic; D Archer
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.